Title: The TMC Worldwide Gene Therapy Enrollment Report, End 1996. Report of TMC Development, Paris, France
Abstract: Human Gene TherapyVol. 8, No. 6 Special FeatureThe TMC Worldwide Gene Therapy Enrollment Report, End 1996. Report of TMC Development, Paris, FranceT. Marcel and J. David GrauszT. MarcelSearch for more papers by this author and J. David GrauszSearch for more papers by this authorPublished Online:20 Mar 2008https://doi.org/10.1089/hum.1997.8.6-775AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byUnusual mechanical stability of a minimal RNA kissing complex24 October 2006 | Proceedings of the National Academy of Sciences, Vol. 103, No. 43Establishment of Modified Retroviral Vector Targeting X-Linked Severe Combined ImmunodeficiencyJournal of Nippon Medical School, Vol. 71, No. 1Evidence That the Mouse 3′ κ Light Chain Enhancer Confers Position-Independent Transgene Expression in T- and B-Lineage Cells Lai Xu, Kazuhide Tsuji, Howard Mostowski, Fabio Candotti, and Amy Rosenberg7 July 2004 | Human Gene Therapy, Vol. 14, No. 18Adenovirus encoding soluble tumor necrosis factor α receptor immunoglobulin prolongs gene expression of a cotransfected reporter gene in rat lungThe Journal of Thoracic and Cardiovascular Surgery, Vol. 126, No. 4Treatment of Human Papillomavirus (HPV) Type 16-Infected Cells Using Herpes Simplex Virus Type 1 Thymidine Kinase-Mediated Gene Therapy Transcriptionally Regulated by the HPV E2 Protein Neerja Sethi and Joel Palefsky6 July 2004 | Human Gene Therapy, Vol. 14, No. 1TK gene combined with mIL-2 and mGM-CSF genes in treatment of gastric cancerWorld Journal of Gastroenterology, Vol. 9, No. 2Bone Morphogenetic Protein Gene TherapySpine, Vol. 27, No. SupplementPolysaccharide−Oligoamine Based Conjugates for Gene Delivery29 March 2002 | Journal of Medicinal Chemistry, Vol. 45, No. 9Metabolic co‐operation between biochemically marked mammalian cells in tissue culture12 March 2002 | Reviews in Medical Virology, Vol. 12, No. 2Continuous isolation of plasmid DNA by annular chromatography4 January 2002 | Biotechnology and Bioengineering, Vol. 77, No. 4Cancer Gene Therapy with the p53 Tumor Suppressor GeneEfficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells9 August 2001 | Cancer Gene Therapy, Vol. 8, No. 6Gene therapy: principles and applications to hematopoietic cells1 May 2001 | Leukemia, Vol. 15, No. 4Gene Therapy for Acute Kidney DiseasesGenetic and Dendritic Cell Vaccination as a Novel Therapy for MelanomaTreatment of a Lysosomal Storage Disease, Mucopolysaccharidosis VII, with Microencapsulated Recombinant Cells C. J. D. Ross, L. Bastedo, S. A. Maier, M. S. Sands, and P. L. Chang6 July 2004 | Human Gene Therapy, Vol. 11, No. 15The 17 Nucleotides Downstream from the env Gene Stop Codon Are Important for Murine Leukemia Virus PackagingJournal of Virology, Vol. 74, No. 18The Bystander Effect Mediated by the New Murine Gammaherpesvirus 72 — Thymidine Kinase/5′-Fluoro-2′-Deoxyuridine (MHV72-TK/5-FUdR) System in Vitro23 June 2016 | Antiviral Chemistry and Chemotherapy, Vol. 11, No. 4Gene therapy for kidney disease24 February 2005 | Expert Opinion on Investigational Drugs, Vol. 9, No. 5Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TK3 May 2000 | Gene Therapy, Vol. 7, No. 8Current and Future Applications of Gene Therapy in Respiratory Disease1 March 2000 | Journal of the Royal College of Physicians of Edinburgh, Vol. 30, No. 1Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in ratsJournal of Neurosurgery, Vol. 92, No. 3In vivo adenovirus-mediated endothelial nitric oxide synthase gene transfer ameliorates lung allograft ischemia-reperfusion injuryThe Journal of Thoracic and Cardiovascular Surgery, Vol. 119, No. 2The potential of gene therapy in the treatment of hepatocellular carcinomaJournal of Hepatology, Vol. 32, No. 2IMPROVED GENE TRANSFER EFFICIENCY IN LIVER WITH VESICULAR STOMATITIS VIRUS G-PROTEIN PSEUDOTYPED RETROVIRUS AFTER PARTIAL LIVER RESECTION AND THYMIDINE KINASE-GANCICLOVIR PRE-TREATMENTPharmacological Research, Vol. 40, No. 5Use of the Peritoneal Cavity for Therapeutic Delivery24 February 2020 | Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, Vol. 19, No. 6Cochlear gene therapy: current perspectivesInternational Journal of Pediatric Otorhinolaryngology, Vol. 49How realistic is cutaneous gene therapy?4 May 2007 | Experimental Dermatology, Vol. 8, No. 5In Vivo Endochondral Bone Formation Using a Bone Morphogenetic Protein 2 Adenoviral Vector Tord D. Alden, Debra D. Pittman, Gerald R. Hankins, Elisa J. Beres, Johnathan A. Engh, Subinoy Das, Sarah B. Hudson, Kelvin M. Kerns, David F. Kallmes, and Gregory A. Helm6 July 2004 | Human Gene Therapy, Vol. 10, No. 13In Vivo Kinetics of Transduced Cells in Peripheral T Cell-Directed Gene Therapy: Role of CD8+ Cells in Improved Immunological Function in an Adenosine Deaminase (ADA)−SCID PatientThe Journal of Immunology, Vol. 163, No. 4Encapsulation for Somatic Gene Therapy6 February 2006 | Annals of the New York Academy of Sciences, Vol. 875, No. 1Naked plasmid-mediated gene transfer to skeletal muscle ameliorates diabetes mellitusThe Journal of Gene Medicine, Vol. 1, No. 3Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecksTrends in Biotechnology, Vol. 17, No. 4Cancer gene therapy update29 June 2016 | Journal of Oncology Pharmacy Practice, Vol. 5, No. 1Interleukin-12 Gene Transfer Results in CD8-Dependent Regression of Murine CT26 Liver TumorsAnnals of Surgical Oncology, Vol. 6, No. 2Fiberless Recombinant Adenoviruses: Virus Maturation and Infectivity in the Absence of FiberJournal of Virology, Vol. 73, No. 2Nonviral Gene DeliveryPharmaceutical Perspectives of Nonviral Gene TherapyEnhanced plasma cholesterol lowering effect of retrovirus-mediated LDL receptor gene transfer to WHHL rabbit liver after improved surgical technique and stimulation of hepatocyte proliferation by combined partial liver resection and thymidine kinase– ganciclovir treatment15 January 1999 | Gene Therapy, Vol. 6, No. 1Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP2215 January 1999 | Gene Therapy, Vol. 6, No. 1Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapyJournal of Neurosurgery: Spine, Vol. 90, No. 1Cancer Gene Therapy Using a Replication-Competent Herpes Simplex Virus Type 1 VectorAnnals of Surgery, Vol. 228, No. 3Clinical Aspects of Gene Therapy28 June 2016 | Annals of Pharmacotherapy, Vol. 32, No. 9Gene therapy for tissue repair and regenerationAdvanced Drug Delivery Reviews, Vol. 33, No. 1-2Adenovirus Vectors as Transcomplementing Templates for the Production of Replication Defective Retroviral VectorsBiochemical and Biophysical Research Communications, Vol. 246, No. 3Growth Factors Gene Delivery to Enhance Grafting Circumventing Adenovirus Immune Response to Achieve Long-Term Correction of Genetic Diseases Florence Paillard20 March 2008 | Human Gene Therapy, Vol. 9, No. 4A Phase I Study of the Transplantation of Genetically Marked Autologous Bone Marrow Stromal Cells. University of Toronto, Ontario, Canada Armand Keating, Leanne Berkahn, and Robin Filshie20 March 2008 | Human Gene Therapy, Vol. 9, No. 4Genetic Research as Therapy: Implications of “Gene Therapy” for Informed Consent23 June 2016 | The Journal of Law, Medicine & Ethics, Vol. 26, No. 1Development of Improved Adenosine Deaminase Retroviral VectorsJournal of Virology, Vol. 72, No. 3Strategies of gene transfer to the kidneyKidney International, Vol. 53, No. 2Immuno-Gene Therapy for Myeloma Using Cytokines Suicide Genes Against Brain Tumors Florence Paillard20 March 2008 | Human Gene Therapy, Vol. 9, No. 1Autologous Fibroblasts as Potential Vehicle for Regional Ovarian Cancer Gene TherapyLipid Gene Trasfer, a Story of Simplicity and ComplexityA high-yielding serum-free, suspension cell culture process to manufacture recombinant adenoviral vectors for gene therapySuccessful Peripheral T-Lymphocyte–Directed Gene Transfer for a Patient With Severe Combined Immune Deficiency Caused by Adenosine Deaminase DeficiencyBlood, Vol. 91, No. 1Tumor-Specific Transgene Expression: An Application for Hepatocarcinoma Gene Therapy The Use of Peripheral Blood Hematopoietic Progenitors for Human Immunodeficiency Virus Gene Therapy Florence Paillard20 March 2008 | Human Gene Therapy, Vol. 8, No. 18Advantages of Non-Human Adenoviruses Versus Human Adenoviruses Promoter Attenuation in Gene Therapy: Causes and Remedies Florence Paillard20 March 2008 | Human Gene Therapy, Vol. 8, No. 17Mesothelial Cells: The Panacea for Ex Vivo Gene Therapy? The First Physiologically Regulated Transgene for Gene Therapy: Erythropoietin Florence Paillard20 March 2008 | Human Gene Therapy, Vol. 8, No. 16Characterization of an Internal Ribosomal Entry Segment Within the 5′ Leader of Avian Reticuloendotheliosis Virus Type A RNA and Development of Novel MLV-REV-Based Retroviral Vectors Marcelo López-Lastra, Caroline Gabus, and Jean-Luc Darlix20 March 2008 | Human Gene Therapy, Vol. 8, No. 16No stranger to controversyNature Genetics, Vol. 17, No. 3Bystander Effects in Enzyme/Prodrug Gene Therapy Florence Paillard20 March 2008 | Human Gene Therapy, Vol. 8, No. 15Recent Advances in the Treatment of Malignant Melanoma with Gene Therapy1 October 1997 | Molecular Medicine, Vol. 3, No. 10Gene transfer to hematopoietic cells — the clinical experience24 April 2009 | European Journal of Haematology, Vol. 59, No. 2Gene Therapy of Single-gene Disorders: Preface to the20 November 2010 | Annals of Medicine, Vol. 29, No. 6The Road toward Human Gene Therapy-A 25-year Perspective8 July 2009 | Annals of Medicine, Vol. 29, No. 6 Volume 8Issue 6Apr 1997 InformationCopyright 1997, Mary Ann Liebert, Inc.To cite this article:T. Marcel and J. David Grausz.The TMC Worldwide Gene Therapy Enrollment Report, End 1996. Report of TMC Development, Paris, France.Human Gene Therapy.Apr 1997.775-800.http://doi.org/10.1089/hum.1997.8.6-775Published in Volume: 8 Issue 6: March 20, 2008PDF download
Publication Year: 1997
Publication Date: 1997-04-10
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
Cited By Count: 66
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot